GENEWEL
GENEWEL is a South Korean biomaterial manufacturer and Dongsung Group subsidiary that produces wound care dressings (Medifoam®), post-surgical anti-adhesion products (Guardix®), and hyaluronic acid-based cosmetics materials for healthcare providers and cosmetics OEMs in Korea.
- Company typePrivate
- Founded2000
- HeadquartersSeongnam, South Korea
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What GENEWEL does
GENEWEL (제네웰) is a South Korean biomaterial and life science company founded on July 21, 2000, headquartered in Seongnam with a manufacturing facility in Hwaseong. It operates as a consolidated subsidiary of the Dongsung Group conglomerate. The company develops and manufactures medical devices — primarily wound care dressings under the Medifoam® line (foam, hydrocolloid, liquid, scargel), the Healoderm® wound healing product, and the Guardix®/Guardcel® post-surgical anti-adhesion product family — alongside a secondary line of cosmetics ingredient materials including hyaluronic acid freeze-drying substrates, melting films, and the FOAM CULE foam mask fabric. GENEWEL holds registered trademarks across roughly twelve branded product lines in these categories.
The company's revenue model is straightforward B2B product sales: medical devices are sold directly to healthcare providers (hospitals and clinics) and through the Dongsung Group distribution network, while cosmetics materials are sold as inputs to cosmetics manufacturers. Pricing is not publicly disclosed and the business operates without subscription, licensing, or platform economics. Its FY2024 financial statements show ₩35,766M in revenue (approximately USD 27M), ₩9,284M operating profit (~26% operating margin), and ₩7,978M net profit (~22% net margin), with a balance sheet of ₩50,388M in total assets and low leverage (₩7,108M total liabilities). FY2024 revenue grew approximately 10% year-over-year off a flat FY2022–FY2023 base.
GENEWEL's operating footprint is concentrated in South Korea, with stated corporate ambition to evolve into a "global life science company" but no disclosed international revenue, regulatory clearances abroad, or named export channels. The CEO is Sang-Deok Han (한상덕). The company maintains a multilingual corporate website (Korean, English, Chinese) and has not pursued public listing, external venture funding, or M&A activity within the available data.
GENEWEL firmographics
Firmographics- Name
- GENEWEL
- Legal name
- Genewel
- Website
- https://genewel.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- GENEWEL is a South Korean biomaterial manufacturer and Dongsung Group subsidiary that produces wound care dressings (Medifoam®), post-surgical anti-adhesion products (Guardix®), and hyaluronic acid-based cosmetics materials for healthcare providers and cosmetics OEMs in Korea.
- Ownership category
- akta.pro rank
GENEWEL industry classification
Industry- Product category
- Medical Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads) (IMAMAGAF)
- akta.pro secondary industries
- Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics) (IMAOADAD), Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
Keywords
Where GENEWEL is headquartered
LocationHeadquarters
- HQ city
- Seongnam
- HQ country
- South Korea
- HQ region
- Asia
Offices2 records
Markets served
GENEWEL business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Device Sales: Sales of biomaterial-based medical devices including wound dressings (foam, hydrocolloid, liquid), anti-adhesion products, and other medical supplies primarily to healthcare providers
- Cosmetics Materials Sales: Sales of cosmetics ingredient materials including hyaluronic acid freeze-drying materials, melting films, and foam fabric to consumer product manufacturers
Distribution channels3 records
Marketing channels3 records
GENEWEL product offering
Product offeringCore offering
GENEWEL manufactures and sells biomaterial-based medical devices — primarily wound dressings (foam, hydrocolloid, liquid, scargel) and post-surgical anti-adhesion products — along with hyaluronic acid-based cosmetic ingredient materials (freeze-dried materials, melting films, foam mask fabrics) supplied to healthcare providers and cosmetics manufacturers. The company operates a manufacturing facility in Hwaseong and a headquarters in Seongnam, South Korea, and is a subsidiary of the Dongsung Group.
Product overview
GENEWEL is a Korean life science company specializing in biomaterials, offering two main product categories: healthcare/biomaterial medical devices and consumer cosmetics materials. The medical device portfolio includes wound care products under brands such as Medifoam® (foam, hydrocolloid, liquid, and scargel dressings), Healoderm®, Guardix®, Guardcel®, Regencol®, Matigen®, Welstop®, Welpass®, Aniguard®, Petera Bandage®, Bariex®, and Barivell®, among others. The consumer/cosmetics segment provides hyaluronic acid-based materials including freeze-drying materials, melting films, mask pack fabrics (FOAM CULE), and HealMyze® products. The company positions these offerings under a unified life science solution umbrella, with wound dressings and anti-adhesives as major product lines.
Differentiator
Problem solved
Functional benefit
Products and services
- Medifoam® Foam Dressing
Companies that use GENEWEL
Customer profileSegments2 records
Ideal customer profiles2 records
GENEWEL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
GENEWEL partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Dongsung ChemicalcoreParent company and primary affiliated entity within the Dongsung Group. Genewel operates as a subsidiary with shared resources, distribution networks, and group-wide marketing initiatives. The company is part of the Dongsung Group family of companies.
- Dongsung FinetecminorAffiliated company within the Dongsung Group network. Operates under the same corporate umbrella with shared brand presence and cross-marketing opportunities through group websites.
- HealMizeminorAffiliated consumer health brand within the Dongsung Group. Listed as a family site company with joint brand presence and potential cross-marketing synergies in the consumer health and cosmetics segments.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
GENEWEL competitors and assessment
Company assessmentDirect peers
- ConvaTec: Global advanced wound care leader with foam, hydrocolloid, and antimicrobial dressings (e.g., AQUACEL, Foam Lite) that compete directly with GENEWEL's Medifoam® portfolio in hospitals and post-acute care.
- Mölnlycke Health Care: Premium wound care and surgical solutions company anchored by Mepilex foam dressings and single-use surgical products, directly comparable to GENEWEL's Medifoam® dressings and Guardix® anti-adhesion franchise.
- Baxter International: Holds the Seprafilm anti-adhesion franchise, the most direct global incumbent comparable to GENEWEL's Guardix® post-surgical adhesion prevention product in surgical settings.
- Hollister Incorporated: Privately held medical products company specializing in wound care, ostomy, and continence care, with overlapping foam and advanced dressing SKUs targeting the same hospital and post-acute customer base.
Broad incumbents
- Smith & Nephew: Large diversified medical devices company with a strong Advanced Wound Management portfolio (Allevyn, PICO) overlapping with GENEWEL's foam and hydrocolloid dressing categories.
- Coloplast: Danish wound and skin care specialist with Biatain foam and hydrocolloid dressings, operating in the same advanced wound care category as GENEWEL with strong hospital channel presence.
- 3M Health Care: Broad medical products business with Tegaderm foam and hydrocolloid dressings as well as skin and wound care lines that overlap with GENEWEL's hospital-channel wound care portfolio.
Regional players
- Daewoong Pharmaceutical: Leading Korean pharmaceutical and medical device company with adjacent wound care, dermatology, and biomaterial products; competes with GENEWEL in the same domestic Korean hospital and consumer channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
GENEWEL social profiles
Digital presenceGENEWEL financial estimates
Financial estimateRevenue estimate
Valuation estimate
GENEWEL leadership team
Management profileNumber of profiles
Profiles1 record
GENEWEL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GENEWEL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GENEWEL
What does GENEWEL do?
GENEWEL manufactures and sells biomaterial-based medical devices — primarily wound dressings (foam, hydrocolloid, liquid, scargel) and post-surgical anti-adhesion products — along with hyaluronic acid-based cosmetic ingredient materials (freeze-dried materials, melting films, foam mask fabrics) supplied to healthcare providers and cosmetics manufacturers. The company operates a manufacturing facility in Hwaseong and a headquarters in Seongnam, South Korea, and is a subsidiary of the Dongsung Group.
Is GENEWEL a public or private company?
GENEWEL is a private company. It is classified as corporate owned and is currently operating.
When was GENEWEL founded?
GENEWEL was founded in 2000. It employs 101 to 250 people.
Where is GENEWEL based?
GENEWEL is headquartered in Seongnam, South Korea, in the Asia region.
How does GENEWEL make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are cosmetics Materials Sales.
Who are GENEWEL's main competitors?
Direct peers on record are ConvaTec, Mölnlycke Health Care, Baxter International and Hollister Incorporated. Broad incumbents are Smith & Nephew, Coloplast and 3M Health Care. Daewoong Pharmaceutical is listed as a regional player.
Does GENEWEL have an API?
No public API is recorded for GENEWEL.
What industry is GENEWEL in?
GENEWEL's product category is Medical Devices. Its primary akta.pro industry code is IMAMAGAF, Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads), with a secondary code of IMAOADAD, Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics). Its NAICS code is 33911 and its SIC code is 3841.